Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Journal for Immunotherapy of Cancer|January 24, 2018
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerationsJun Gong, Alexander Chehrazi-Raffle, Srikanth Reddi, et al.Oncotarget|July 17, 2024
Targeting the multifaceted BRAF in cancer: New directionsEamon Toye, Alexander Chehrazi-Raffle, Justin Hwang, et al.Cancers|March 6, 2021
Wnt/β-Catenin Signaling and Immunotherapy Resistance: Lessons for the Treatment of Urothelial CarcinomaAlexander Chehrazi-Raffle, Tanya B Dorff, Sumanta K Pal, et al.Clinical and Translational Medicine|March 20, 2019
The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategiesJun Gong, Alexander Chehrazi-Raffle, Veronica Placencio-Hickok, et al.Cancers|February 11, 2023
An Update on the Treatment of Papillary Renal Cell CarcinomaNeal S Chawla, Nicolas Sayegh, Sweta Prajapati, et al.Cancer Journal (Sudbury, Mass.)|September 18, 2020
Immune Related Adverse Events: Classification and Management Approaches in Advanced Kidney CancerZeynep B Zengin, Nicholas J Salgia, Alexander Chehrazi-Raffle, et al.The Oncologist|June 14, 2023
Activity of Tivozanib in Non-clear Cell Renal Cell Carcinoma: Subgroup Analysis From a Phase II Randomized Discontinuation TrialPedro C Barata, Alexander Chehrazi-Raffle, Kimberly D Allman, et al.Journal for Immunotherapy of Cancer|March 10, 2021
Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinomaAlexander Chehrazi-Raffle, Luis Meza, Marice Alcantara, et al.Clinical Genitourinary Cancer|December 12, 2022
Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint InhibitorsNeal S Chawla, Nicolas Sayegh, Nishita Tripathi, et al.Frontiers in Immunology|January 23, 2024
Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapyMarice B Alcantara, Wilson S Tang, Dongfang Wang, et al.Pageof 4